Shionogi & Co. Ltd.

In News

Why Shionogi (TSE:4507) Is Up 5.4% After Winning Pediatric Approval For VTAMA Cream – And What’s Next - Yahoo Finance

Yahoo Finance - Sep 18, 2026

Shionogi (TSE:4507) Wins New Drug Approvals On Questions Over Whether The Value Case Still Holds - simplywall.st

simplywall.st - Sep 17, 2026

Shionogi and The Bloc launch “Make the Call” campaign to raise awareness of COVID-19 prevention therapy - PharmaLive

PharmaLive - Sep 15, 2026

Shionogi taps The Bloc for omnichannel campaign backing COVID-19 pill Xocova - Fierce Pharma

Fierce Pharma - Sep 15, 2026

Shionogi CEO says firm is pursuing acquisitions and mulling expanded U.S. production - The Japan Times

The Japan Times - Aug 05, 2026

Shionogi & Co., Ltd.- Covgoze For Intramuscular Injection (Jn.1-Adapted), Recombinant Protein Covid-19 Vaccine, Receives Partial Change Approval In Japan - TradingView

TradingView - Sep 16, 2026

Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026 - BioSpace

BioSpace - Sep 09, 2026

(ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure* - Business Wire

Business Wire - Jul 28, 2026

Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats - CIDRAP

CIDRAP - Apr 09, 2026

Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats - Pharmaceutical Executive

Pharmaceutical Executive - Apr 09, 2026

Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi - PR Newswire

PR Newswire - Apr 01, 2026

Shionogi-Backed Apnimed Seeks to Raise $160 Million in US IPO - Bloomberg.com

Bloomberg.com - Jul 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment